share_log

We Think That There Are More Issues For Haohua Chemical Science & Technology (SHSE:600378) Than Just Sluggish Earnings

We Think That There Are More Issues For Haohua Chemical Science & Technology (SHSE:600378) Than Just Sluggish Earnings

我們認爲,昊華化學科技(SHSE: 600378)面臨的問題不僅僅是收益疲軟
Simply Wall St ·  05/06 02:55

A lackluster earnings announcement from Haohua Chemical Science & Technology Corp., Ltd. (SHSE:600378) last week didn't sink the stock price. However, we believe that investors should be aware of some underlying factors which may be of concern.

昊華化學科技股份有限公司(SHSE: 600378)上週公佈的業績乏善可陳,但並未使股價下跌。但是,我們認爲,投資者應注意一些可能令人擔憂的潛在因素。

earnings-and-revenue-history
SHSE:600378 Earnings and Revenue History May 6th 2024
SHSE: 600378 收益和收入歷史記錄 2024 年 5 月 6 日

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

For anyone who wants to understand Haohua Chemical Science & Technology's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥83m worth of unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. Which is hardly surprising, given the name. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

對於任何想了解昊華化學科技超出法定數字的利潤的人來說,值得注意的是,在過去的十二個月中,從價值8300萬元人民幣的不尋常物品中獲得了法定利潤。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們分析全球絕大多數上市公司時,我們發現重大不尋常的事項往往不會重演。考慮到這個名字,這並不奇怪。假設這些不尋常的項目在本年度不會再次出現,因此我們預計明年的利潤將疲軟(也就是說,在業務沒有增長的情況下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Haohua Chemical Science & Technology's Profit Performance

我們對昊華化學科技盈利表現的看法

Arguably, Haohua Chemical Science & Technology's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Haohua Chemical Science & Technology's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 13% per annum growth in EPS for the last three. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Haohua Chemical Science & Technology as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 1 warning sign for Haohua Chemical Science & Technology you should be aware of.

可以說,浩華化學科技的法定收益被提高利潤的不尋常項目所扭曲。因此,在我們看來,皓華化學科技的真正潛在盈利能力實際上可能低於其法定利潤。但是,至少持有人可以從過去三年的每股收益每年增長13%中得到一些安慰。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。如果您想進一步了解浩華化學科技作爲一家企業,請務必了解其面臨的任何風險。一個很好的例子:我們發現了你應該注意的皓華化學科技的1個警告信號。

Today we've zoomed in on a single data point to better understand the nature of Haohua Chemical Science & Technology's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying to be useful.

今天,我們放大了單個數據點,以更好地了解昊華化學科技利潤的性質。但是,還有很多其他方法可以讓你對公司的看法。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論